NCT05979675招募中不适用
Acute Myeloid Leukemia Registry - Prospective National Multicentric Observational Study
Turkish Hematology Association1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2021年12月21日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 250
- 试验地点
- 1
- 主要终点
- Overall Survival
研究概览
简要总结
All acute myeloid leukemia (AML) patients diagnosed after 1 Jan 2020 will be included to this study.
详细描述
This is a non interventional prospective disease registry, 250 prospective patients diagnosed with AML across 20 centers in Turkey.
Participating sites will consist of hematology clinics and routine follow-up procedures will be followed-up.
All patients diagnosed after 1 Jan 2020 as AML will be included and patients will be enrolled during 24 months of period and will be followed-up 36 months. Study will be completed in 60 months.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed as AML after 1 Jan 2020
- •Patients signed informed consent form
排除标准
- •Patients under 18 years old
结局指标
主要结局
Overall Survival
时间窗: 60 months
From diagnosis to exits by any cause
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)Acute Myeloid Leukemia (AML)NCT03188874Technische Universität Dresden15,000
招募中
不适用
The newly diagnosed acute myeloid leukemia registry and ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) sample collections for further investigating about molecular mutationsThe patients 18 years and older who were diagnosis and known to have acute leukemia Myeloid.Acute leukemia Myeloid ,ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) sample collections for further investigating about molecular mutationsTCTR20201027001Siriraj Hospital Mahidol University139
Unknown
不适用
Prospective Database for Acute Myeloblastic LeukemiaLeukemia, Myeloblastic, AcuteNCT00538278King Faisal Specialist Hospital & Research Center2,000
招募中
不适用
A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)AL AmyloidosisNCT06205953Fondazione IRCCS Policlinico San Matteo di Pavia400
终止
1 期
Study to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)Acute Myeloid LeukemiaNCT06068868AbbVie36